Recap: Spero Therapeutics Q4 Earnings
Recap: Spero Therapeutics Q4 Earnings
Spero Therapeutics (NASDAQ:SPRO) reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:05 PM.
Spero Therapeutics（纳斯达克股票代码：SPRO）于2024年3月13日星期三下午4点05分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Spero Therapeutics beat estimated earnings by 1060.0%, reporting an EPS of $0.96 versus an estimate of $-0.1.
Spero Therapeutics的收益比预期高出1060.0％，每股收益为0.96美元，而估计为-0.1美元。
Revenue was up $26.08 million from the same period last year.
收入比去年同期增长了2608万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company missed on EPS by $0.03 which was followed by a 2.0% drop in the share price the next day.
上个季度，该公司的每股收益下跌了0.03美元，随后第二天股价下跌了2.0％。
Here's a look at Spero Therapeutics's past performance:
以下是 Spero Therapeutics 过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.34 | -0.33 | 0.04 |
| EPS Actual | -0.06 | -0.23 | -0.25 | 0.55 |
| Revenue Estimate | 14.97M | 1.07M | 1.00M | 22.87M |
| Revenue Actual | 25.47M | 2.72M | 2.07M | 47.44M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.03 | -0.34 | -0.33 | 0.04 |
| 实际每股收益 | -0.06 | -0.23 | -0.25 | 0.55 |
| 收入估算 | 14.97 亿 | 1.07M | 1.00M | 22.87 米 |
| 实际收入 | 25.47 亿 | 2.72M | 2.07 米 | 47.44M |
To track all earnings releases for Spero Therapeutics visit their earnings calendar here.
要追踪Spero Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。
译文内容由第三方软件翻译。